Skip to content

Factors Influencing the 3-Year Recurrence of Liver Carcinoma After Surgery

Factors Influencing the 3-Year Recurrence of Liver Carcinoma After Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02941861
Enrollment
67
Registered
2016-10-21
Start date
2016-08-31
Completion date
2016-09-30
Last updated
2016-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Cancer, Recurrence

Keywords

Hepatocellular carcinoma, Cholangiocarcinoma, Recurrence

Brief summary

Objective: 1. To study the factors that influence the 3- year recurrence of liver carcinoma after surgery 2. To study the related factors affecting recurrence of liver carcinoma after surgery

Detailed description

Liver carcinoma including 80% Hepatocellular carcinoma (HCC) and 20% Cholangiocarcinoma (CCA) becomes the leading causes of death in East and South-East Asia. Though hepatectomy is the treatment of choice for early stage cancer, the recurrence has been reported as 30%, 62% and 79% in 1st, 3rd and 5th year respectively. Chulabhorn hospital, a cancer institute established in 2011, has been performing a 3-years retrospective study on the influencing factors and its correlation to liver carcinoma after surgery.

Interventions

OTHERRecurrence Rate of HCC after surgery

Recurrence Rate of HCC after surgery

OTHERRecurrence Rate of CCA after surgery

Recurrence Rate of CCA after surgery

Sponsors

Ruechuta Molek
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All patients underwent liver resection for Hepatiocellular carcinoma and Cholangiocarcinoma respectively including having pathology results between February 2010 to December 2013. Data was received from Cholabhron Hospital's patient database.

Exclusion criteria

* All patients having no pathology results were not included. * All patients having no show for follow up recording were excluded.

Design outcomes

Primary

MeasureTime frame
Recurrence rate of Liver Carcinoma after surgery3 years

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026